Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Dollar Outlook Remains Positive Near-Term But Less So Longer-Term -- Market Talk

Dollar Outlook Remains Positive Near-Term But Less So Longer-Term -- Market Talk

Dow JonesDow Jones2026/09/28 10:26

1026 GMT - The dollar could remain firm in the near term but the longer-term outlook is becoming less favorable for the currency, Societe Generale's Kit Juckes says in a note. Elevated oil prices, robust U.S. economic data and a more risk-averse global environment support the dollar, he says. Further out, November's midterm elections make it difficult for President Trump to maintain accommodative fiscal policies that have supported the economy and the dollar, he says. "The world's major savings economies are saving less than they once did, while the U.S. is having to pay more to attract the investment it needs." The DXY dollar index rises 0.1% to 101.101. (renae.dyer@wsj.com)

(END) Dow Jones Newswires

September 28, 2026 06:26 ET (10:26 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

US LNG Exports Reach Record High as Europe and Asia Hope for Winter Price Relief

U.S. liquefied natural gas exports have reached record highs, potentially easing market pressures caused by war-related disruptions.

智通财经•2026/11/16 07:01
US LNG Exports Reach Record High as Europe and Asia Hope for Winter Price Relief

Light-asset cross-border logistics service provider CloudDepots sets IPO pricing at $5 to $6, aiming to raise up to $17 million

Logistics service provider CloudDepots Holdings has filed for a $17 million initial public offering.

智通财经•2026/11/16 06:58
Light-asset cross-border logistics service provider CloudDepots sets IPO pricing at $5 to $6, aiming to raise up to $17 million

Inflammatory disease biotechnology company Rezera (RZRA.US) delays $200 million IPO in the US

Biotechnology company Rezera announced last Thursday that it will postpone its listing.

智通财经•2026/11/16 06:58
Inflammatory disease biotechnology company Rezera (RZRA.US) delays $200 million IPO in the US